Structures by: Arman H. D.
Total: 209
Chlorido(4-chloro-2,2':6',2''-terpyridine-κ^3^<i>N</i>,<i>N</i>',<i>N</i>'')(trifluoromethanesulfonato-κ<i>O</i>)zinc(II) acetonitrile monosolvate
C16H10Cl2F3N3O3SZn,C2H3N
IUCrData (2020) 5, 9
a=7.6550(14)Å b=15.329(3)Å c=18.486(4)Å
α=90° β=92.088(7)° γ=90°
C15H24O
C15H24O
Journal of Natural Products (2019)
a=5.15450(10)Å b=14.0173(4)Å c=18.2753(4)Å
α=90° β=90° γ=90°
C15H26O2
C15H26O2
Journal of Natural Products (2019)
a=7.6289(2)Å b=13.0886(3)Å c=14.6321(3)Å
α=90° β=90° γ=90°
C21H16N2O
C21H16N2O
Organic letters (2016) 18, 22 5808-5811
a=7.5003(3)Å b=8.4300(2)Å c=12.7367(7)Å
α=91.619(4)° β=101.145(4)° γ=98.005(3)°
2-Methylnaphthalen-1-yl(S,E)-4-(4-fluorophenyl)-2-{(S)-[(4-methylphenyl) sulfonamido](phenyl)methyl}but-3-enoate dimethyl sulfoxide solvate
C35H30FNO4S,C2H6OS
Organic letters (2016) 18, 11 2648-2651
a=8.6308(13)Å b=13.950(2)Å c=15.866(3)Å
α=102.470(11)° β=103.640(11)° γ=105.496(13)°
ZnTETA
C78H82N4O16Zn3.solvent
Materials Chemistry Frontiers (2017) 1, 8 1514
a=11.4427(17)Å b=14.514(2)Å c=16.196(3)Å
α=65.694(5)° β=69.783(5)° γ=73.998(5)°
3-(2-Hydroxy-2-phenylethyl)-4-methyl-2,5-dihydrothiophene-1,1-dioxide
C13H16O3S
Organic & biomolecular chemistry (2018) 16, 19 3605-3609
a=13.4091(3)Å b=7.52720(10)Å c=13.3823(3)Å
α=90° β=114.262(3)° γ=90°
C13H14ClNOS
C13H14ClNOS
Organic & biomolecular chemistry (2014) 12, 32 6190-6199
a=9.1435(17)Å b=6.0132(11)Å c=23.209(5)Å
α=90.00° β=90.530(3)° γ=90.00°
2-Phenylpyridine N-Oxide
C11H9NO
Chemical communications (Cambridge, England) (2016) 52, 64 9945-9948
a=5.8141(14)Å b=23.591(5)Å c=6.8413(16)Å
α=90° β=114.257(3)° γ=90°
3-Methylquinoline N-Oxide meta-Chlorobenzoic Acid (1:1) Complex
C7H5ClO2,C10H9NO
Chemical communications (Cambridge, England) (2016) 52, 64 9945-9948
a=15.840(4)Å b=13.517(4)Å c=7.047(2)Å
α=90° β=101.395(5)° γ=90°
6-Methoxuquinoline N-Oxide Dihydrate
C10H9NO2,2(H2O)
Chemical communications (Cambridge, England) (2016) 52, 64 9945-9948
a=4.8503(12)Å b=17.114(4)Å c=6.4411(15)Å
α=90° β=105.911(4)° γ=90°
4-Methylquinoline N-Oxide Dihydrate
C10H9NO,2(H2O)
Chemical communications (Cambridge, England) (2016) 52, 64 9945-9948
a=6.690(4)Å b=8.863(5)Å c=9.115(6)Å
α=107.219(6)° β=111.191(11)° γ=92.478(5)°
6,6'-Di-tert-butyl-2,2'-biquinoline
C26H28N2
Chemical communications (Cambridge, England) (2016) 52, 64 9945-9948
a=18.301(11)Å b=6.133(3)Å c=18.738(11)Å
α=90° β=94.032(6)° γ=90°
3-Methylisoquinoline N-Oxide Dihydrate
C10H9NO,2(H2O)
Chemical communications (Cambridge, England) (2016) 52, 64 9945-9948
a=6.8201(14)Å b=16.879(3)Å c=9.0566(19)Å
α=90° β=106.250(3)° γ=90°
HOF-4
C61H48N20
Chem.Commun. (2014) 50, 13081
a=20.212(6)Å b=7.275(2)Å c=26.666(8)Å
α=90.00° β=90.606(6)° γ=90.00°
8,8'-Biquinoline 1,1'-dioxide
C18H12N2O2
Chem.Commun. (2015) 51, 9507
a=7.720(5)Å b=21.073(12)Å c=8.161(5)Å
α=90.00° β=92.202(10)° γ=90.00°
6,6'-Diisopropyl-2,2'-biquinoline
C24H24N2
Chemical communications (Cambridge, England) (2016) 52, 64 9945-9948
a=12.648(15)Å b=5.914(7)Å c=13.125(17)Å
α=90° β=94.02(2)° γ=90°
5,5'-Diphenyl-2,2'-bipyridine
2(C11H8N)
Chemical communications (Cambridge, England) (2016) 52, 64 9945-9948
a=20.260(12)Å b=5.434(3)Å c=16.088(9)Å
α=90° β=110.528(9)° γ=90°
C22H46BCoNP2
C22H46BCoNP2
Dalton transactions (Cambridge, England : 2003) (2018) 47, 5 1435-1441
a=15.2602(10)Å b=11.3904(6)Å c=15.6393(12)Å
α=90° β=112.919(8)° γ=90°
C22H42CoN2OP2
C22H42CoN2OP2
Dalton transactions (Cambridge, England : 2003) (2018) 47, 5 1435-1441
a=7.7482(3)Å b=14.9473(8)Å c=10.7812(6)Å
α=90° β=97.987(4)° γ=90°
C23H43CoNO2P2
C23H43CoNO2P2
Dalton transactions (Cambridge, England : 2003) (2018) 47, 5 1435-1441
a=10.6498(4)Å b=15.2862(5)Å c=15.6734(6)Å
α=90° β=97.796(4)° γ=90°
C17H27CoNO12P3Ru
C17H27CoNO12P3Ru
Dalton transactions (Cambridge, England : 2003) (2017) 46, 4 1186-1193
a=16.740(3)Å b=11.664(2)Å c=12.351(2)Å
α=90.00° β=90.00° γ=90.00°
C20H44CoN3O12P3Ru,2(CF3O3S)
C20H44CoN3O12P3Ru,2(CF3O3S)
Dalton transactions (Cambridge, England : 2003) (2017) 46, 4 1186-1193
a=20.084(3)Å b=12.6011(17)Å c=16.863(2)Å
α=90° β=93.902(2)° γ=90°
C21H29CoNO12P3Ru
C21H29CoNO12P3Ru
Dalton transactions (Cambridge, England : 2003) (2017) 46, 4 1186-1193
a=10.4496(16)Å b=11.5244(17)Å c=22.855(4)Å
α=90° β=97.413(3)° γ=90°
C25H43CoNO12P3Ru
C25H43CoNO12P3Ru
Dalton transactions (Cambridge, England : 2003) (2017) 46, 4 1186-1193
a=16.170(3)Å b=17.167(3)Å c=24.094(4)Å
α=90° β=90° γ=90°
C17H23Br4CoNO12P3Ru
C17H23Br4CoNO12P3Ru
Dalton transactions (Cambridge, England : 2003) (2017) 46, 4 1186-1193
a=24.071(3)Å b=14.2382(17)Å c=17.677(2)Å
α=90° β=90° γ=90°
2-mercaptobenzimidazole-1,2-diiodo-3,4,5,6-tetrafluorobenzene (1/1)
C13H6F4I2N2S
Chemical communications (Cambridge, England) (2010) 46, 11 1854-1856
a=8.2368(14)Å b=8.5594(15)Å c=12.643(3)Å
α=88.742(17)° β=85.274(16)° γ=66.509(10)°
Thiourea-1,4-diiodo-2,3,5,6-tetrafluorobenzene (1/1)
C7H4F4I2N2S
Chemical communications (Cambridge, England) (2010) 46, 11 1854-1856
a=11.6519(18)Å b=8.6561(14)Å c=23.639(4)Å
α=90.00° β=91.057(6)° γ=90.00°
Ethylenethiourea-tetraiodoethylene (2/3)
C12H12I12N4S2
Chemical communications (Cambridge, England) (2010) 46, 11 1854-1856
a=19.504(2)Å b=8.2442(9)Å c=20.428(3)Å
α=90.00° β=96.487(9)° γ=90.00°
C53H41Cl4F4FeN4SSi,2(CH2Cl2)
C53H41Cl4F4FeN4SSi,2(CH2Cl2)
Dalton transactions (Cambridge, England : 2003) (2015) 44, 20 9486-9495
a=11.785(2)Å b=21.887(4)Å c=12.845(2)Å
α=90.00° β=117.1275(19)° γ=90.00°
(4-Chloro-2,2':6',2''-terpyridine-κ^3^<i>N</i>,<i>N</i>',<i>N</i>'')bis(nitrato-κ<i>O</i>)zinc(II)
C15H10ClN5O6Zn
IUCrData (2020) 5, 10 x201344
a=12.1001(19)Å b=13.3139(18)Å c=13.4869(12)Å
α=62.471(9)° β=63.694(7)° γ=87.388(11)°
4-Amino-<i>N</i>-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide--1,4-diazabicyclo[2.2.2]octane (2/1)
2(C12H14N4O2S),C6H12N2
Acta Crystallographica Section E (2013) 69, 11 o1615
a=26.488(3)Å b=9.7886(11)Å c=12.2163(13)Å
α=90.00° β=90.00° γ=90.00°
Bis[μ~2~-<i>N</i>-(2-hydroxyethyl)-<i>N</i>-isopropylcarbamodithioato-κ^3^<i>S</i>:<i>S</i>,<i>S</i>]bis{[<i>N</i>-(2-hydroxyethyl)-<i>N</i>-isopropylcarbamodithioato-κ^2^<i>S</i>,<i>S</i>'](3-{(1<i>E</i>)-[(<i>E</i>)-2-(pyridin-3-ylmethylidene)hydrazin-1-ylidene]methyl}pyridine-κ<i>N</i>)cadmium]} dihydrate
C48H68Cd2N12O4S8,2(H2O)
Acta Crystallographica Section E (2016) 72, 9 1234-1238
a=16.4700(18)Å b=12.2257(12)Å c=17.0862(19)Å
α=90° β=114.932(2)° γ=90°
[μ~2~-<i>trans</i>-1,2-Bis(pyridin-4-yl)ethene-κ^2^<i>N</i>:<i>N</i>]bis{[1,2-bis(pyridin-4-yl)ethene-κ<i>N</i>]bis[<i>N</i>-(2-hydroxyethyl)-<i>N</i>-<i>N</i>-isopropyldithiocarbamato-κ^2^<i>S</i>,<i>S</i>']cadmium} acetonitrile tetrasolvate:
C60H78Cd2N10O4S8,4(C2H3N)
Acta Crystallographica Section E (2016) 72, 8 1085-1092
a=16.884(2)Å b=14.4021(15)Å c=17.327(2)Å
α=90° β=109.112(3)° γ=90°
{μ~2~-<i>N</i>,<i>N</i>-bis[(pyridin-3-yl)methyl]ethanediamide}tetrakis(dimethylcarbamodithioato)dizinc(II) dimethylformamide disolvate
C26H38N8O2S8Zn2,2(C3H7NO)
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 10 1501-1507
a=9.0998(8)Å b=9.3544(10)Å c=15.508(2)Å
α=84.1760(10)° β=75.540(8)° γ=61.067(6)°
{μ~2~-<i>N</i>,<i>N</i>-Bis[(pyridin-3-yl)methyl]ethanediamide}tetrakis(di-<i>n</i>-propylcarbamodithioato)dizinc(II)
C42H70N8O2S8Zn2
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 10 1501-1507
a=31.048(4)Å b=16.923(2)Å c=10.3453(14)Å
α=90° β=100.361(2)° γ=90°
Poly[[bis[μ~2~-<i>N</i>-ethyl-<i>N</i>-(pyridin-4-ylmethyl)dithiocarbamato-\ κ^3^<i>N</i>:<i>S</i>,<i>S</i>]cadmium(II)] 3-methylpyridine monosolvate]
C18H22CdN4S4,C6H7N
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 4 488-492
a=9.5842(15)Å b=11.0788(16)Å c=12.989(2)Å
α=90° β=100.014(4)° γ=90°
2-[(<i>E</i>)-(5-<i>tert</i>-butyl-2-hydroxyphenyl)diazenyl]benzoic acid
C17H18N2O3
Acta Crystallographica Section E (2008) 64, 11 o2125
a=5.9052(19)Å b=10.872(4)Å c=23.126(8)Å
α=90° β=94.432(4)° γ=90°
<i>N</i>-(4,6-Dimethylpyrimidin-2-yl)-4-(oxolan-2-ylamino)benzenesulfonamide
C16H20N4O3S
Acta Crystallographica Section E (2009) 65, 11 o2851
a=10.291(5)Å b=9.592(4)Å c=17.196(8)Å
α=90° β=106.445(10)° γ=90°
2-hydrocy-5-[(4-methylphenyl)diazenyl]benzaldehyde
C14H12N2O2
Acta Crystallographica Section E (2009) 65, 12 o3061
a=6.016(4)Å b=14.299(9)Å c=26.878(17)Å
α=90° β=90° γ=90°
1-[3,5-Bis(trifluoromethyl)phenyl]-3-[(5-ethenyl-1-azabicyclo[2.2.2]octan- 2-yl)(6-methoxyquinolin-4-yl)methyl]thiourea--L-proline--methanol (1/1/1)
C29H28F6N4OS,C5H9NO2,CH4O
Acta Crystallographica Section E (2009) 65, 12 o3070
a=11.597(3)Å b=13.044(4)Å c=23.907(7)Å
α=90° β=90° γ=90°
4-(Dimethylamino)pyridinium 2-(4-hydroxyphenyldiazenyl)benzoate
C7H11N2,C13H9N2O3
Acta Crystallographica Section E (2009) 65, 12 o3226
a=9.240(4)Å b=10.924(4)Å c=17.598(7)Å
α=90° β=92.002(8)° γ=90°
2-[(4-Hydroxyphenyl)diazenyl]benzoic acid--<i>N</i>,<i>N</i>'-bis(4-pyridylmethyl)oxamide (2/1)
2(C13H10N2O3),C14H14N4O2
Acta Crystallographica Section E (2009) 65, 12 o3178-o3179
a=5.523(3)Å b=11.132(4)Å c=15.066(7)Å
α=72.748(16)° β=88.92(2)° γ=79.43(2)°
Potassium 2-[(2-carboxyphenyl)disulfanyl]benzoate--2,2'-disulfanediyldibenzoic acid (1/1)
K,C14H9O4S2,C14H10O4S2
Acta Crystallographica Section E (2009) 65, 12 o3202
a=11.1128(14)Å b=12.1225(15)Å c=12.5344(12)Å
α=65.501(8)° β=64.216(8)° γ=80.144(10)°
2-pyridone
C5H5N1O1
Acta Crystallographica Section E (2009) 65, 12 o3187
a=6.2027(13)Å b=16.327(4)Å c=9.1046(18)Å
α=90° β=92.242(7)° γ=90°
(5-Ethenyl-1-azabicyclo[2.2.2]octan-2-yl)(6-methoxy-3-quinolyl)methanol methanol solvate
C20H24N2O2,CH4O
Acta Crystallographica Section E (2009) 65, 11 o2962
a=9.5374(13)Å b=12.9842(17)Å c=15.871(2)Å
α=90° β=90° γ=90°
(μ-<i>trans</i>-1,2-Di-4-pyridylethylene- κ^2^<i>N</i>:<i>N</i>)bis[bis(<i>N</i>,<i>N</i>- diethyldithiocarbamato-κ^2^<i>S</i>,<i>S</i>')zinc(II)] chloroform solvate
C32H50N6S8Zn2,CHCl3
Acta Crystallographica Section E (2009) 65, 11 m1472-m1473
a=17.443(3)Å b=15.739(3)Å c=16.823(3)Å
α=90° β=90° γ=90°
(μ-<i>trans</i>-1,2-Di-4-pyridylethylene- κ^2^<i>N</i>:<i>N</i>)bis[bis(<i>N</i>,<i>N</i>-diisopropyldithiocarbamato- κ^2^<i>S</i>,<i>S</i>')zinc(II)]
C40H66N6S8Zn2
Acta Crystallographica Section E (2009) 65, 11 m1475
a=8.2690(14)Å b=11.1640(18)Å c=14.156(2)Å
α=80.806(10)° β=84.878(9)° γ=72.566(5)°
4,4'-Bipyridine--pyroglutamic acid (1/2)
C10H8N2,2(C5H7NO3)
Acta Crystallographica Section E (2009) 65, 11 o2950
a=7.444(3)Å b=11.511(4)Å c=12.845(4)Å
α=66.274(17)° β=74.203(17)° γ=86.91(2)°
Dichlorido(4,7-diaza-1-azoniacyclononane- κ^2^<i>N</i>^4^,<i>N</i>^7^)palladium(II) <i>p</i>-toluenesulfonate
C6H16Cl2N3Pd,C7H7O3S
Acta Crystallographica Section E (2010) 66, 6 m638-m639
a=6.6663(11)Å b=7.0023(11)Å c=19.646(3)Å
α=92.149(3)° β=92.301(3)° γ=103.084(4)°
Benzoic acid--2,9-dimethylphenanthroline (1/1)
C7H6O2,C14H12N2
Acta Crystallographica Section E (2010) 66, 8 o2117
a=13.575(5)Å b=11.645(4)Å c=11.148(4)Å
α=90° β=104.832(6)° γ=90°
Benzene-1,3-diol--1,4-diazabicyclo[2.2.2]octane (1/1)
C6H12N2,C6H6O2
Acta Crystallographica Section E (2010) 66, 8 o2188
a=9.3620(19)Å b=23.645(5)Å c=11.072(2)Å
α=90° β=112.64(3)° γ=90°
2-(4-Chlorophenyl)acetic acid--2-{(<i>E</i>)-[(<i>E</i>)-2-(2-pyridylmethylidene)hydrazin-1- ylidene]methyl}pyridine (1/1)
C8H7ClO2,C12H10N4
Acta Crystallographica Section E (2010) 66, 9 o2356
a=11.740(6)Å b=4.641(2)Å c=33.451(15)Å
α=90° β=90° γ=90°
1,2,4,5-Tetrafluoro-3,6-diiodobenzene--2,3-bis(pyridin-2-yl)pyrazine (1/1)
C14H10N4,C6F4I2
Acta Crystallographica Section E (2010) 66, 11 o2885
a=6.3997(15)Å b=10.737(2)Å c=15.092(4)Å
α=74.237(10)° β=85.877(11)° γ=80.283(12)°
4-Amino-<i>N</i>-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide--benzoic acid (1/1)
C12H14N4O2S,C7H6O2
Acta Crystallographica Section E (2010) 66, 9 o2430
a=15.203(6)Å b=14.006(5)Å c=18.015(7)Å
α=90° β=90° γ=90°
Poly[(μ~2~-2,2-bipyridine-κ^2^<i>N</i>:<i>N'</i>)bis(μ~3~-2,2,2- trifluoroacetato-κ^3^<i>O</i>:<i>O</i>:<i>O</i>')disilver(I)]
C14H8Ag2F6N2O4
Acta Crystallographica Section E (2010) 66, 10 m1209-m1210
a=24.597(6)Å b=6.8474(14)Å c=21.253(5)Å
α=90° β=116.029(4)° γ=90°
<i>catena</i>-Poly[[[(2-pyridone-κ<i>O</i>)silver(I)]-μ-2-pyridone- κ^2^<i>O</i>:<i>O</i>] hexafluoridophosphate]
C20H20AgN4O4,F6P
Acta Crystallographica Section E (2010) 66, 10 m1212
a=13.519(5)Å b=24.187(9)Å c=7.301(3)Å
α=90° β=96.918(5)° γ=90°
Aqua(trifluoromethanesulfonato)bis(1,3,7-trimethylpurine-2,6-dione)silver(I)
C17H22AgF3N8O8S
Acta Crystallographica Section E (2010) 66, 10 m1211
a=8.9012(10)Å b=10.0408(8)Å c=15.457(2)Å
α=72.091(7)° β=85.444(9)° γ=63.672(6)°
1,2,4,5-Tetrafluoro-3,6-diiodobenzene--4-(pyridin-4-ylsulfanyl)pyridine (1/1)
C10H8N2S,C6F4I2
Acta Crystallographica Section E (2010) 66, 10 o2683
a=13.804(5)Å b=5.829(2)Å c=22.164(8)Å
α=90° β=97.989(7)° γ=90°
2-Phenylacetic acid--3-{(<i>E</i>)-2-[(<i>E</i>)-pyridin-3-ylmethylidene]hydrazin-1- ylidenemethyl}pyridine (2/1)
C12H10N4,2(C8H8O2)
Acta Crystallographica Section E (2010) 66, 10 o2684
a=5.511(2)Å b=9.536(4)Å c=12.434(6)Å
α=80.30(2)° β=88.45(3)° γ=76.46(2)°
Benzoic acid--4-{(1<i>E</i>)-[(<i>E</i>)-2-(pyridin-4-ylmethylidene)hydrazin- 1-ylidene]methyl}pyridine (2/1)
C12H10N4,2(C7H6O2)
Acta Crystallographica Section E (2010) 66, 11 o2924
a=6.873(6)Å b=26.059(19)Å c=7.117(6)Å
α=90° β=116.245(13)° γ=90°
2,2'-(disulfanediyl)dibenzoic acid--<i>N</i>,<i>N</i>'-bis(3-pyridylmethyl)ethanediamide (1/1)
C14H14N4O2,C14H10O4S2
Acta Crystallographica Section E (2010) 66, 10 o2590-o2591
a=10.015(3)Å b=10.310(3)Å c=14.795(4)Å
α=86.910(16)° β=78.052(15)° γ=69.554(10)°
2,2'-(Disulfanediyl)dibenzoic acid--<i>N</i>,<i>N</i>'-bis(4-pyridylmethyl)ethanedithioamide (1/1)
C14H14N4S2,C14H10O4S2
Acta Crystallographica Section E (2010) 66, 10 o2592
a=18.502(5)Å b=10.624(3)Å c=15.026(4)Å
α=90° β=110.235(5)° γ=90°
Benzoic acid--2-{(<i>E</i>)-[(<i>E</i>)-2-(2-pyridylmethylidene)hydrazin-1- ylidene]methyl}pyridine (2/1)
C12H10N4,2(C7H6O2)
Acta Crystallographica Section E (2010) 66, 11 o2813
a=4.4509(7)Å b=11.3635(17)Å c=12.0612(17)Å
α=108.985(6)° β=99.830(9)° γ=97.849(10)°
2-Phenylacetic acid--(<i>E</i>,<i>E</i>)-4,4'-(hydrazinediylidene)dipyridine (2/1)
C12H10N4,2(C8H8O2)
Acta Crystallographica Section E (2010) 66, 10 o2629
a=11.677(7)Å b=4.425(2)Å c=23.587(13)Å
α=90.00° β=95.475(8)° γ=90.00°
Poly[[bis[μ~2~-<i>N</i>,<i>N</i>-bis(2-pyridylmethyl)oxalamide- κ^4^<i>N</i>,<i>O</i>:<i>N</i>',<i>O</i>'][μ~2~-<i>N</i>,<i>N</i>'- bis(2-pyridylmethyl)oxalamide-κ^2^<i>N</i>:<i>N</i>']disilver(I)] bis(trifluoromethanesulfonate)]
C21H21AgN6O3,CF3O3S
Acta Crystallographica Section E (2010) 66, 9 m1167-m1168
a=8.7242(14)Å b=11.1762(17)Å c=14.210(2)Å
α=95.9770(10)° β=105.948(2)° γ=107.017(3)°
2,2'-(Disulfanediyl)dibenzoic acid--2,9-dimethylphenanthroline--tetrahydrofuran (1/2/1)
C14H10O4S2,2(C14H12N2),C4H8O
Acta Crystallographica Section E (2010) 66, 10 o2602
a=14.011(4)Å b=8.516(3)Å c=17.403(5)Å
α=90° β=109.637(6)° γ=90°
Bis[<i>N</i>-(2-hydroxyethyl)-<i>N</i>-methyldithiocarbamato-κ<i>S</i>][2,4,6- tris(pyridin-2-yl)-1,3,5-triazine-κ^3^<i>N</i>^1^,<i>N</i>^2^,<i>N</i>^6^]zinc dioxane sesquisolvate
C26H28N8O2S4Zn,1.5(C4H8O2)
Acta Crystallographica Section E (2012) 68, 3 m319-m320
a=11.863(10)Å b=13.019(11)Å c=13.199(11)Å
α=107.214(12)° β=105.780(15)° γ=100.892(11)°
{[Ethyl(pyridin-4-ylmethyl)carbamothioyl]sulfanido-κ^2^<i>S</i>,<i>S</i>}(1,4,7,10,13,16-hexaoxacyclooctadecane-κ^6^<i>O</i>)potassium
C21H35KN2O6S2
Acta Crystallographica Section E (2013) 69, 9 m479-m480
a=17.077(3)Å b=17.816(3)Å c=8.5107(17)Å
α=90.00° β=96.010(3)° γ=90.00°
Bis(2,9-dimethyl-1,10-phenanthrolin-1-ium) 2,5-dicarboxybenzene-1,4-dicarboxylate--2,9-dimethyl-1,10-phenanthroline--benzene-1,2,4,5-tetracarboxylic acid (1/2/1)
2(C14H13N2),C10H6O82,2(C14H12N2),C10H4O8
Acta Crystallographica Section E (2013) 69, 9 o1445-o1446
a=11.798(4)Å b=13.893(4)Å c=19.163(6)Å
α=90° β=92.216(5)° γ=90°
2-Aminobenzoic acid--4,4'-bipyridine (2/1)
C10H8N2,2(C7H7NO2)
Acta Crystallographica Section E (2013) 69, 9 o1447
a=10.782(5)Å b=10.998(5)Å c=8.951(4)Å
α=90.00° β=107.215(7)° γ=90.00°
Benzene-1,2,4,5-tetracarboxylic acid bis(1,3,7-trimethyl-2,3,6,7-tetrahydro-1<i>H</i>-purine-2,6-dione)
C10H6O8,2(C8H10N4O2)
Acta Crystallographica Section E (2013) 69, 9 o1443
a=7.4570(15)Å b=9.0490(15)Å c=11.782(2)Å
α=68.800(11)° β=81.124(13)° γ=73.441(9)°
4-[2-(Pyridin-1-ium-4-yl)ethyl]pyridin-1-ium bis(2,6-dinitrobenzoate)
C12H14N22,2(C7H3N2O6)
Acta Crystallographica Section E (2013) 69, 11 o1606
a=6.6916(12)Å b=8.3690(17)Å c=12.358(3)Å
α=88.809(12)° β=76.322(8)° γ=72.193(9)°
4-Amino-<i>N</i>-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide--1,4-diazabicyclo[2.2.2]octane (2/1)
2(C12H14N4O2S),C6H12N2
Acta Crystallographica Section E (2013) 69, 11 o1615
a=26.488(3)Å b=9.7886(11)Å c=12.2163(13)Å
α=90.00° β=90.00° γ=90.00°
4-Aza-1-azoniabicyclo[2.2.2]octane--2-aminobenzoate--2-aminobenzoic acid (1/1/1)
C6H13N2,C7H6NO2,C7H7NO2
Acta Crystallographica Section E (2011) 67, 11 o2933
a=9.285(3)Å b=16.843(5)Å c=12.660(4)Å
α=90° β=102.127(6)° γ=90°
<i>N</i>,<i>N</i>'-Bis[(pyridin-1-ium-2-yl)methyl]ethanedithioamide bis(2,6-dinitrobenzoate)--2,6-dinitrobenzoic acid (1/4)
C14H16N4S22,2(C7H3N2O6),4(C7H4N2O6)
Acta Crystallographica Section E (2013) 69, 10 o1506-o1507
a=11.157(2)Å b=11.524(3)Å c=14.967(4)Å
α=79.601(18)° β=72.859(17)° γ=61.237(12)°
2-Aminobenzoic acid--4-(pyridin-4-yldisulfanyl)pyridine (1/1)
C7H7NO2,C10H8N2S2
Acta Crystallographica Section E (2011) 67, 12 o3361
a=8.636(2)Å b=12.728(3)Å c=15.688(4)Å
α=90° β=103.218(4)° γ=90°
<i>tert</i>-Butyl(2-hydroxyethyl)azanium 4-[(1,3-thiazol-2-ylazanidyl)sulfonyl]aniline
C6H16NO,C9H8N3O2S2
Acta Crystallographica Section E (2012) 68, 9 o2662-o2663
a=13.893(3)Å b=11.771(3)Å c=22.191(5)Å
α=90° β=91.401(4)° γ=90°
4-Amino-<i>N</i>-(2,3-dihydro-1,3-thiazol-2-ylidene)benzenesulfonamide; 2,4,6-tris(pyridin-2-yl)-1,3,5-triazine
C18H12N6,C9H9N3O2S2
Acta Crystallographica Section E (2014) 70, 4 o402-o403
a=8.8109(13)Å b=12.7222(16)Å c=13.1696(14)Å
α=66.227(6)° β=73.797(6)° γ=88.068(9)°
4-Carboxypyridin-1-ium 2,4,5-tricarboxybenzoate monohydrate
C6H6NO2,C10H5O8,H2O
Acta Crystallographica Section E (2013) 69, 7 o1122-o1123
a=9.724(2)Å b=10.007(2)Å c=10.755(2)Å
α=99.560(10)° β=114.667(8)° γ=110.283(9)°
2-Aminobenzoic acid--4-[2-(pyridin-4-yl)ethyl]pyridine (2/1)
C12H12N2,2(C7H7NO2)
Acta Crystallographica Section E (2013) 69, 11 o1616
a=11.305(2)Å b=11.102(2)Å c=8.8737(16)Å
α=90.00° β=94.565(5)° γ=90.00°
C26H33NO4S
C26H33NO4S
ACS Medicinal Chemistry Letters (2020)
a=9.18072(12)Å b=9.24659(12)Å c=26.9361(3)Å
α=90° β=90° γ=90°
C19H26O2
C19H26O2
ACS Medicinal Chemistry Letters (2020)
a=7.6756(2)Å b=20.7238(5)Å c=9.8982(3)Å
α=90° β=100.184(2)° γ=90°
C19H26O2
C19H26O2
ACS Medicinal Chemistry Letters (2020)
a=9.1412(2)Å b=9.1412(2)Å c=18.5205(6)Å
α=90° β=90° γ=90°
C5H6N6,2(C3H7NO)
C5H6N6,2(C3H7NO)
Crystal Growth & Design (2014) 14, 7 3634
a=13.978(4)Å b=8.0838(19)Å c=13.895(4)Å
α=90.00° β=105.158(4)° γ=90.00°
C5H6N6
C5H6N6
Crystal Growth & Design (2014) 14, 7 3634
a=18.711(3)Å b=18.711(3)Å c=10.843(2)Å
α=90.00° β=90.00° γ=120.00°
C23H38O3,3/4(H2O),CH4O
C23H38O3,3/4(H2O),CH4O
ACS Catalysis (2019) 9, 10 9485
a=12.5451(2)Å b=25.5594(4)Å c=15.6511(3)Å
α=90° β=110.747(2)° γ=90°
C22H19N
C22H19N
ACS Catalysis (2019) 9, 10 9485
a=8.8592(3)Å b=22.1890(5)Å c=8.9840(3)Å
α=90° β=114.717(4)° γ=90°
C21H17N
C21H17N
ACS Catalysis (2019) 9, 10 9485
a=18.1884(4)Å b=10.5558(2)Å c=25.3027(7)Å
α=90° β=108.216(3)° γ=90°
C15H17N3O4S
C15H17N3O4S
ACS Catalysis (2019) 9, 10 9485
a=13.3181(12)Å b=6.9639(4)Å c=17.0635(15)Å
α=90° β=90.091(8)° γ=90°
0.5(H4O2),2(C64H104O6)
0.5(H4O2),2(C64H104O6)
ACS Catalysis (2020) 10, 19 11448-11457
a=27.5054(2)Å b=7.15900(10)Å c=28.9864(2)Å
α=90° β=91.0090(10)° γ=90°
C15H20O2
C15H20O2
ACS Catalysis (2020) 10, 19 11448-11457
a=6.46515(12)Å b=7.56208(15)Å c=26.4823(6)Å
α=90° β=93.8866(18)° γ=90°
C20H24O5S2
C20H24O5S2
ACS Catalysis (2020) 10, 19 11448-11457
a=13.16970(10)Å b=8.54580(10)Å c=33.8861(3)Å
α=90° β=90° γ=90°
C20H30BNO4
C20H30BNO4
ACS Catalysis (2020) 10, 19 11448-11457
a=13.4325(4)Å b=9.9472(3)Å c=15.5089(5)Å
α=90° β=101.160(3)° γ=90°
C20H22F2O4S2
C20H22F2O4S2
ACS Catalysis (2020) 10, 19 11448-11457
a=11.66361(12)Å b=15.02503(19)Å c=11.25687(12)Å
α=90° β=97.1362(10)° γ=90°
C16H26O2
C16H26O2
ACS Catalysis (2020) 10, 19 11448-11457
a=23.9880(3)Å b=6.72515(7)Å c=18.4587(2)Å
α=90° β=109.4427(12)° γ=90°
C37H56O3S
C37H56O3S
ACS Catalysis (2020) 10, 19 11448-11457
a=14.75517(10)Å b=11.91670(8)Å c=18.31913(11)Å
α=90° β=93.7103(6)° γ=90°
C56H42N24OZn
C56H42N24OZn
Crystal Growth & Design (2015) 15, 4 2000
a=13.5570(10)Å b=17.2802(15)Å c=19.7405(16)Å
α=89.109(6)° β=83.989(6)° γ=73.423(5)°
MA-1-H2O
C3H6N6
Crystal Growth & Design (2015) 15, 4 1871
a=7.2789(3)Å b=7.4799(3)Å c=10.3316(4)Å
α=90.00° β=108.495(4)° γ=90.00°
Melamine
2(C3H6N6),C7H8
Crystal Growth & Design (2015) 15, 4 1871
a=12.2365(8)Å b=12.2365(8)Å c=24.574(3)Å
α=90.00° β=90.00° γ=90.00°